These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8070085)

  • 1. Tamm-Horsfall glycoprotein: role in inhibition and promotion of renal calcium oxalate stone formation studied with Fourier-transform infrared spectroscopy.
    Knörle R; Schnierle P; Koch A; Buchholz NP; Hering F; Seiler H; Ackermann T; Rutishauser G
    Clin Chem; 1994 Sep; 40(9):1739-43. PubMed ID: 8070085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tamm-Horsfall protein in recurrent calcium kidney stone formers with positive family history: abnormalities in urinary excretion, molecular structure and function.
    Jaggi M; Nakagawa Y; Zipperle L; Hess B
    Urol Res; 2007 Apr; 35(2):55-62. PubMed ID: 17345077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A simple diagnostic method for the differentiation of Tamm-Horsfall glycoproteins from healthy probands and those from recurrent calcium oxalate renal stone formers.
    Schnierle P
    Experientia; 1995 Nov; 51(11):1068-72. PubMed ID: 7498447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tamm-Horsfall glycoprotein--inhibitor or promoter of calcium oxalate monohydrate crystallization processes?
    Hess B
    Urol Res; 1992; 20(1):83-6. PubMed ID: 1736492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Tamm-Horsfall protein and uromodulin in calcium oxalate crystallization.
    Carvalho M; Mulinari RA; Nakagawa Y
    Braz J Med Biol Res; 2002 Oct; 35(10):1165-72. PubMed ID: 12424489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isoelectric focusing of Tamm-Horsfall glycoproteins: a simple tool for recognizing recurrent calcium oxalate renal stone formers.
    Schnierle P; Hering F; Seiler H
    Urol Res; 1996; 24(2):79-82. PubMed ID: 8740976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Tamm-Horsfall protein with normal and reduced sialic acid content upon the crystallization of calcium phosphate and calcium oxalate in human urine.
    Hallson PC; Choong SK; Kasidas GP; Samuell CT
    Br J Urol; 1997 Oct; 80(4):533-8. PubMed ID: 9352687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular abnormality of Tamm-Horsfall glycoprotein in calcium oxalate nephrolithiasis.
    Hess B; Nakagawa Y; Parks JH; Coe FL
    Am J Physiol; 1991 Apr; 260(4 Pt 2):F569-78. PubMed ID: 2012207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological detection of nitrosative stress-mediated modified Tamm-Horsfall glycoprotein (THP) in calcium oxalate stone formers.
    Pragasam V; Kalaiselvi P; Sumitra K; Srinivasan S; Anandkumar P; Varalakshmi P
    Biomarkers; 2006; 11(2):153-63. PubMed ID: 16766391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of urinary excretion of Tamm-Horsfall protein in non-selected kidney stone formers and healthy subjects.
    Glauser A; Hochreiter W; Jaeger P; Hess B
    Nephrol Dial Transplant; 2000 Oct; 15(10):1580-7. PubMed ID: 11007825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tamm-Horsfall glycoprotein and calcium nephrolithiasis.
    Hess B
    Miner Electrolyte Metab; 1994; 20(6):393-8. PubMed ID: 7783702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Tamm-Horsfall protein and albumin on calcium oxalate crystallization and importance of sialic acids.
    Chen WC; Lin HS; Chen HY; Shih CH; Li CW
    Mol Urol; 2001; 5(1):1-5. PubMed ID: 11689144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of Tamm-Horsfall glycoprotein and Nephrocalcin in calcium oxalate monohydrate crystallization processes.
    Hess B
    Scanning Microsc; 1991 Sep; 5(3):689-95; discussion 696. PubMed ID: 1808706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients with recurrent renal stones have a physico-chemically altered urinary Tamm-Horsfall glycoprotein profile.
    Jefferson A; Reynolds TM; Elves A; Wierzbicki AS
    Ann Clin Biochem; 1996 Nov; 33 ( Pt 6)():540-4. PubMed ID: 8937586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Citrate and calcium effects on Tamm-Horsfall glycoprotein as a modifier of calcium oxalate crystal aggregation.
    Hess B; Zipperle L; Jaeger P
    Am J Physiol; 1993 Dec; 265(6 Pt 2):F784-91. PubMed ID: 8285211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary Tamm-Horsfall protein increased after potassium citrate therapy in calcium stone formers.
    Fuselier HA; Ward DM; Lindberg JS; Allen JM; Husserl FE; Marcucci PA; Cole FE; Turnipseed J; Alam J; Kok DJ
    Urology; 1995 Jun; 45(6):942-6. PubMed ID: 7771027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Tamm-Horsfall protein on calcium oxalate precipitation.
    Benković J; Furedi-Milhofer H; Hlady V; Cvorisćec D; Stavljenić-Rukavina A
    Eur J Clin Chem Clin Biochem; 1995 Oct; 33(10):705-10. PubMed ID: 8608191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tamm and Horsfall glycoprotein does not promote spontaneous precipitation and crystal growth of calcium oxalate in vitro.
    Kitamura T; Pak CY
    J Urol; 1982 May; 127(5):1024-6. PubMed ID: 7086979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Citrate determines calcium oxalate crystallization kinetics and crystal morphology-studies in the presence of Tamm-Horsfall protein of a healthy subject and a severely recurrent calcium stone former.
    Hess B; Jordi S; Zipperle L; Ettinger E; Giovanoli R
    Nephrol Dial Transplant; 2000 Mar; 15(3):366-74. PubMed ID: 10692522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tamm-Horsfall protein is a critical renal defense factor protecting against calcium oxalate crystal formation.
    Mo L; Huang HY; Zhu XH; Shapiro E; Hasty DL; Wu XR
    Kidney Int; 2004 Sep; 66(3):1159-66. PubMed ID: 15327412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.